Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden

被引:216
作者
Lawes, CMM
Vander Hoorn, S
Law, MR
Elliott, P
MacMahon, S
Rodgers, A
机构
[1] Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand
[2] Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, Dept Environm & Prevent Med, London, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England
[4] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia
关键词
attributable burden; blood pressure; cardiovascular disease; world health;
D O I
10.1097/01.hjh.0000209973.67746.f0
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives To provide estimates of the global burden of disease attributable to non-optimal blood pressure by age and sex for adults aged >= 30 years, by WHO subregion. Methods Estimates of attributable burden were made using population impact fractions, which used data on mean systolic blood pressure levels, disease burden [in deaths and/or disability-adjusted life years (DALYs)] and relative risk corrected for regression dilution bias. Estimates were made of burden attributable to a population distribution of blood pressure with a mean systolic blood pressure of greater than 115 mmHg. Results Globally, approximately two-thirds of stroke and one-half of ischaemic heart disease were attributable to non-optimal blood pressure. These proportions were highest in the more developed parts of the world. Worldwide, 7.1 million deaths (approximately 12.8% of the global total) and 64.3 million DALYs (4.4% of the global total) were estimated to be due to non-optimal blood pressure. Overall approximately, two-thirds of the attributable burden of disease occurred in the developing world, approximately two-thirds in the middle age groups (45-69 years) and approximately one-half occurred in those with systolic blood pressure levels between 130 and 150 mmHg. Conclusions The burden of non-optimal blood pressure is almost double that of the only previous global estimates, which is largely explained by the correction for regression dilution adopted in these analyses. High blood pressure is a leading cause of global burden of disease, and most of it occurs in the developing world.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 35 条
[1]  
[Anonymous], 2002, GLOBAL BURDEN DIS 20
[2]  
[Anonymous], 1996, GLOBAL BURDEN DIS IN
[3]  
[Anonymous], 2002, RED RISKS PROM HLTH
[4]   BLOOD-PRESSURE IN 4 REMOTE POPULATIONS IN THE INTERSALT STUDY [J].
CARVALHO, JJM ;
BARUZZI, RG ;
HOWARD, PF ;
POULTER, N ;
ALPERS, MP ;
FRANCO, LJ ;
MARCOPITO, LF ;
SPOONER, VJ ;
DYER, AR ;
ELLIOTT, P ;
STAMLER, J ;
STAMLER, R .
HYPERTENSION, 1989, 14 (03) :238-246
[5]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[6]   PLASMA-LIPIDS, LIPOPROTEINS, AND DIET OF TARAHUMARA INDIANS OF MEXICO [J].
CONNOR, WE ;
CERQUEIRA, MT ;
CONNOR, RW ;
WALLACE, RB ;
MALINOW, MR ;
CASDORPH, HR .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1978, 31 (07) :1131-1142
[7]   Quantifying risk of death and disability associated with raised blood pressure [J].
Elliott, P ;
Nichols, R ;
Chee, D .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (5-6) :571-582
[8]   Selected major risk factors and global and regional burden of disease [J].
Ezzati, M ;
Lopez, AD ;
Rodgers, A ;
Vander Hoorn, S ;
Murray, CJL .
LANCET, 2002, 360 (9343) :1347-1360
[9]   Estimates of global and regional potential health gains from reducing multiple major risk factors [J].
Ezzati, M ;
Vander Hoorn, S ;
Rodgers, A ;
Lopez, AD ;
Mathers, CD ;
Murray, CJL .
LANCET, 2003, 362 (9380) :271-280
[10]  
He J, 1991, Epidemiology, V2, P88, DOI 10.1097/00001648-199103000-00002